Group 1 - The core viewpoint of the news is the performance and holdings of the Ping An Medical Health Mixed C fund, which has shown significant growth in recent months and year-to-date [1] - As of August 18, 2025, the latest net value of the fund is 2.9725 yuan, reflecting a growth of 1.24% [1] - The fund's one-month return is 2.68%, six-month return is 81.82%, and year-to-date return is 92.00%, with respective rankings of 1127 out of 1212, 8 out of 1181, and 9 out of 1179 [1] Group 2 - The top ten stock holdings of the Ping An Medical Health Mixed C fund account for a total of 75.91%, with the largest holding being Ginkgo BioWorks at 10.55% [1] - Other significant holdings include Innovent Biologics (9.08%), CanSino Biologics (8.97%), and BeiGene (7.58%) [1] - The fund was established on November 28, 2023, and as of June 30, 2025, it has a total scale of 1.216 billion yuan, managed by fund manager Zhou Sicong [1][2]
8月18日平安医疗健康混合C净值增长1.24%,今年来累计上涨92.0%
Sou Hu Cai Jing·2025-08-18 12:08